Genzyme Rejects Sanofi’s $18.5 Billion Offer

U.S. biotech company Genzyme Inc. (GENZ) rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA (SNY) on Monday, setting the stage for a protracted and potentially hostile takeover battle. – Reuters

Jasper - The Real Deal!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.